Becton, Dickinson and Company vs Pfizer, Inc. — Stock Comparison
Q·Score Breakdown
6.7
Neutral
Overall
6.5
Neutral
Quality
Health
Growth
Valuation
Sentiment
BDX
Consensus analyst target of $191.46 is 28% above current price.
⚠ analyst sentiment is cautious.
PFE
Strong profitability with 12% net profit margins.
⚠ analyst sentiment is cautious.
Analyst Consensus
HOLD
Target $191.46 (+28.2%)
13 analysts
HOLD
Target $29.00 (+10.2%)
27 analysts
Fundamentals
BDX
PFE
24.4×
Trailing P/E
19.4×
11.1×
Forward P/E
9.4×
8.0%
Profit Margin
12.4%
46.8%
Gross Margin
75.8%
7.0%
ROE
8.9%
1.6%
Revenue Growth
-1.2%
28.6%
Earnings Growth
—
0.35
Beta
0.39
—
Price / Book
—
$42.5B
Market Cap
$149.8B
$128 – $187
52-Week Range
$22 – $29
Q·Score is an educational tool and is not financial advice. Data provided by Yahoo Finance. Updated on each page load. How it's calculated →